Katherine E Burdick

Summary

Affiliation: Long Island Jewish Medical Center
Country: USA

Publications

  1. ncbi Genetic variation in DTNBP1 influences general cognitive ability
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Albert Einstein College of Medicine, Glen Oaks, NY 11004, USA
    Hum Mol Genet 15:1563-8. 2006
  2. pmc Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability
    Katherine E Burdick
    Hillside Hospital, North Shore Long Island Jewish Health System, Department of Psychiatry Research, Glen Oaks, NY 11004, USA
    Am J Psychiatry 167:436-43. 2010
  3. ncbi COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance
    Katherine E Burdick
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 9:370-6. 2007
  4. pmc DTNBP1 genotype influences cognitive decline in schizophrenia
    Katherine E Burdick
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, United States
    Schizophr Res 89:169-72. 2007
  5. pmc Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Hum Mol Genet 17:2462-73. 2008
  6. doi Neurocognitive profile analysis in obsessive-compulsive disorder
    Katherine E Burdick
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    J Int Neuropsychol Soc 14:640-5. 2008
  7. ncbi Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy
    Katherine E Burdick
    Department of Psychiatry, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    CNS Drugs 21:971-81. 2007
  8. doi Attention and psychomotor functioning in bipolar depression
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System and Albert Einstein College of Medicine, Glen Oaks, NY, USA
    Psychiatry Res 166:192-200. 2009
  9. pmc Emotional modulation of response inhibition in stable patients with bipolar I disorder: a comparison with healthy and schizophrenia subjects
    Chaya B Gopin
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Bipolar Disord 13:164-72. 2011
  10. ncbi DISC1 and neurocognitive function in schizophrenia
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York, USA
    Neuroreport 16:1399-402. 2005

Research Grants

  1. Neurocognition as an endophenotype in bipolar disorder
    Katherine Burdick; Fiscal Year: 2008

Detail Information

Publications56

  1. ncbi Genetic variation in DTNBP1 influences general cognitive ability
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Albert Einstein College of Medicine, Glen Oaks, NY 11004, USA
    Hum Mol Genet 15:1563-8. 2006
    ..These data suggest that DTNBP1 genetic variation influences human intelligence...
  2. pmc Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability
    Katherine E Burdick
    Hillside Hospital, North Shore Long Island Jewish Health System, Department of Psychiatry Research, Glen Oaks, NY 11004, USA
    Am J Psychiatry 167:436-43. 2010
    ..Thus, MET may be of particular interest as a candidate gene for neuropsychiatric diseases with a developmental etiology, including schizophrenia...
  3. ncbi COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance
    Katherine E Burdick
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 9:370-6. 2007
    ..A large body of evidence suggests that COMT is associated with cognitive performance in patients with schizophrenia and in healthy volunteers but there have been no reports of its relationship to cognition in BPD...
  4. pmc DTNBP1 genotype influences cognitive decline in schizophrenia
    Katherine E Burdick
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, United States
    Schizophr Res 89:169-72. 2007
    ..The current study assessed the relationship between intellectual decline in schizophrenia and genetic variation in dysbindin-1 (DTNBP1)...
  5. pmc Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Hum Mol Genet 17:2462-73. 2008
    ..These data suggest that NDEL1 significantly influences risk for SZ via an interaction with DISC1. We propose a model where NDEL1 and NDE1 compete for binding with DISC1...
  6. doi Neurocognitive profile analysis in obsessive-compulsive disorder
    Katherine E Burdick
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    J Int Neuropsychol Soc 14:640-5. 2008
    ..Findings of specific abnormalities on tasks of motor and processing speed are consistent with a hypothesized role of thalamocortical and basal ganglia regions in the pathogenesis of OCD...
  7. ncbi Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy
    Katherine E Burdick
    Department of Psychiatry, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    CNS Drugs 21:971-81. 2007
    ..Finally, psychosocial intervention and/or cognitive remediation should be considered as alternatives to medications, although these techniques will also require additional systematic study...
  8. doi Attention and psychomotor functioning in bipolar depression
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System and Albert Einstein College of Medicine, Glen Oaks, NY, USA
    Psychiatry Res 166:192-200. 2009
    ..Associations among indices of attention deficits and psychomotor slowing may be indicative of similarities in the underlying neurobiology of these frequently co-occurring symptom domains in depressed individuals with bipolar disorder...
  9. pmc Emotional modulation of response inhibition in stable patients with bipolar I disorder: a comparison with healthy and schizophrenia subjects
    Chaya B Gopin
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Bipolar Disord 13:164-72. 2011
    ..We examined the pattern of affective processing in stable BD patients and compared their profile to that of healthy controls (HC) and patients diagnosed with schizophrenia (SZ)...
  10. ncbi DISC1 and neurocognitive function in schizophrenia
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York, USA
    Neuroreport 16:1399-402. 2005
    ..These data suggest that DISC1 is associated with neurocognitive functioning in schizophrenia...
  11. ncbi Assessing cognitive deficits in bipolar disorder: are self-reports valid?
    Katherine E Burdick
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Psychiatry Res 136:43-50. 2005
    ..Such discrepancies could relate to impaired insight, efforts to conceal deficits, or to subthreshold affective symptoms...
  12. pmc The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders
    Katherine E Burdick
    Feinstein Institute for Medical Research, Center for Translational Psychiatry, Manhasset, New York, USA
    Cogn Neuropsychiatry 14:299-311. 2009
    ....
  13. pmc Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance
    Carolin Opgen-Rhein
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, United States
    Schizophr Res 103:169-77. 2008
    ..Our aim in this study was to investigate the relationship between DAOA variation and schizophrenia, and the influence of DAOA on cognitive performance...
  14. pmc Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia
    Terry E Goldberg
    Psychiatry Research, Zucker Hillside Hospital, United States
    Schizophr Res 107:262-6. 2009
    ..Furthermore, assuming that cognition is a core symptom of schizophrenia, the notion that ongoing psychosis is somehow toxic for a variety of information processing domains appears questionable...
  15. pmc The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia
    Pamela DeRosse
    Center for Translational Psychiatry, The Feinstein Institute for Medical Research, Manhasset, NY, USA
    Schizophr Bull 34:1047-53. 2008
    ..We examined these chromosomal regions for association to positive, negative, and disorganized symptom clusters, using a dense set of single-nucleotide polymorphisms (SNPs)...
  16. ncbi Dysbindin genotype and negative symptoms in schizophrenia
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Am J Psychiatry 163:532-4. 2006
    ....
  17. pmc DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia
    Philip R Szeszko
    Feinstein Institute for Medical Research, Manhasset, NY, USA
    Biol Psychol 79:103-10. 2008
    ..Given that DISC1 plays a role in cerebral cortex development, polymorphisms in this gene may have relevance for neurobiological models of schizophrenia that have implicated cortical deficits in its pathophysiology...
  18. ncbi Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    Biol Psychiatry 61:1208-10. 2007
    ....
  19. ncbi COMT genotype and manic symptoms in schizophrenia
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, and Harvard Partners Center for Genetics and Genomics, Boston, MA, United States
    Schizophr Res 87:28-31. 2006
    ..These data suggest that the effect of COMT variation may be associated with comorbid manic symptoms in SZ...
  20. pmc Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia
    Todd Lencz
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Proc Natl Acad Sci U S A 104:19942-7. 2007
    ..Other risk ROHs feature haplotypes that are also common in healthy individuals, possibly indicating a source of balancing selection...
  21. ncbi Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Terry E Goldberg
    Zucker Hillside Hospital, 7559 263rd Street, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 64:1115-22. 2007
    ..However, none of these studies included healthy controls undergoing repeated testing to assess the possibility that improvements might reflect simple practice effects...
  22. ncbi Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia
    Katherine E Burdick
    Bipolar Disorders Research Program, Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    J Nerv Ment Dis 194:255-60. 2006
    ..These preliminary findings suggest that neurocognitive domains appear longitudinally stable across broad domains in schizophrenia. In contrast, stable functioning may be more limited to attentional domains in bipolar disorder...
  23. pmc A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes
    Todd Lencz
    Department of Psychiatry, Division of Research, The Zucker Hillside Hospital Division of the North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Neuropsychopharmacology 35:2284-91. 2010
    ..05). The risk allele dosage also predicted impairments on a timed visuomotor performance task (trails A). Results support a role of ZNF804A in phenotypes reflecting altered neural connectivity...
  24. pmc Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes
    Todd Lencz
    The Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd Street, Glen Oaks, New York 11004, USA
    Br J Psychiatry 194:313-8. 2009
    ..Brain-derived neurotrophic factor variants may help clarify the status of schizoaffective disorder...
  25. ncbi Age-related differences in white matter tract microstructure are associated with cognitive performance from childhood to adulthood
    Bart D Peters
    Division of Psychiatry Research BDP, TI, PD, MJ, PRS, AKM, Zucker Hillside Hospital, Glen Oaks, New York Center for Psychiatric Neuroscience BDP, TI, PD, MJ, PRS, AKM, Feinstein Institute for Medical Research, Manhasset, New York Electronic address
    Biol Psychiatry 75:248-56. 2014
    ..In the present cross-sectional study, we examined whether these differences are associated with neurocognitive performance from childhood to late adulthood...
  26. pmc Impulsivity in bipolar disorder: relationships with neurocognitive dysfunction and substance use history
    Robyn L Powers
    Department of Psychiatry Research, The Zucker Hillside Hospital North Shore Long Island Jewish Health System, Glen Oaks, USA
    Bipolar Disord 15:876-84. 2013
    ..Our objective was to assess the relationship between impulsivity and cognition in bipolar disorder...
  27. pmc Assessing the potential to use neurocognition to predict who is at risk for developing bipolar disorder: a review of the literature
    Doreen M Olvet
    Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, New York, NY, USA
    Cogn Neuropsychiatry 18:129-45. 2013
    ..There is some available data to suggest that cognitive deficits may precede the onset of mania; therefore, it would be beneficial to identify cognitive predictors of bipolar disorder in an effort to facilitate early intervention...
  28. pmc The MATRICS consensus cognitive battery in patients with bipolar I disorder
    Katherine E Burdick
    Department of Psychiatry, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Neuropsychopharmacology 36:1587-92. 2011
    ..Additional studies should address important psychometric features such as repeatability and potential practice and/or ceiling effects...
  29. pmc Gray matter structural alterations in obsessive-compulsive disorder: relationship to neuropsychological functions
    Christopher J Christian
    Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    Psychiatry Res 164:123-31. 2008
    ..Moreover, our data suggest that gray matter structural alterations in OCD have neuropsychological correlates, which may be useful in further characterizing structure-function relations in this disorder...
  30. pmc Cognitive and symptomatic predictors of functional disability in schizophrenia
    Syed Shamsi
    Department of Psychiatry, Division of Psychiatry Research, Glen Oaks, NY 11004, United States
    Schizophr Res 126:257-64. 2011
    ..Few studies have assessed the relationship between functional outcomes and the MATRICS consensus cognition battery (MCCB), which will be central to future clinical trials of cognitive enhancing agents...
  31. ncbi Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?
    Anil K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, and Albert Einstein College of Medicine, United States
    Schizophr Res 87:181-4. 2006
    ..We tested the hypothesis that ziprasidone improves cognition in the absence of clinical improvement...
  32. ncbi Deficits in memory strategy use are related to verbal memory impairments in adolescents with schizophrenia-spectrum disorders
    David Roofeh
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Schizophr Res 85:201-12. 2006
    ..To assess the nature of learning and verbal memory deficits in adolescents with schizophrenia-spectrum disorders (SzS) (i.e., schizophrenia, schizoaffective disorder, and schizophreniform disorder)...
  33. pmc Abnormal temporal lobe white matter as a biomarker for genetic risk of bipolar disorder
    Katie Mahon
    Department of Psychiatry and Neuroscience, Mount Sinai School of Medicine, 1 Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    Biol Psychiatry 73:177-82. 2013
    ..The nature of these abnormalities is not well-characterized, however, and it is unknown whether they occur after disease onset or represent potential markers of genetic risk...
  34. pmc Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders
    Serge Sevy
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY, 11004, USA
    Schizophr Res 92:74-84. 2007
    ..To test this hypothesis, we compared schizophrenia patients with (SCZ((+))) or without (SCZ((-))) cannabis use disorders, to healthy subjects, on measures of cognition and IGT performance...
  35. pmc Cannabis use disorders in schizophrenia: effects on cognition and symptoms
    Pamela DeRosse
    Center for Translational Psychiatry, The Feinstein Institute for Medical Research, Manhasset, NY, USA
    Schizophr Res 120:95-100. 2010
    ..Although several studies have suggested that CUD in patients with SZ may be associated with variation in cognitive function, clinical presentation and course of illness, the effects have been inconsistent...
  36. pmc Clinical and cognitive correlates of suicide attempts in bipolar disorder: is suicide predictable?
    Alison M Gilbert
    Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    J Clin Psychiatry 72:1027-33. 2011
    ..We conducted a retrospective investigation of potential clinical, demographic, and neuropsychological risk factors for suicide attempts in patients diagnosed with bipolar disorder...
  37. ncbi Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome
    Kelly L Cervellione
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    J Am Acad Child Adolesc Psychiatry 46:867-78. 2007
    ..Here, the authors examined the longitudinal stability of neuropsychological deficits in adolescents with EOS relative to HCS and the associations of these deficits with short-term functional outcome in patients...
  38. ncbi Early-onset schizophrenia is associated with impaired adolescent development of attentional capacity using the identical pairs continuous performance test
    Emily Thaden
    The Zucker Hillside Hospital, Department of Psychiatry Research 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Schizophr Res 81:157-66. 2006
    ....
  39. pmc Empirical support for DSM-IV schizoaffective disorder: clinical and cognitive validators from a large patient sample
    Pamela DeRosse
    Center for Translational Psychiatry, The Feinstein Institute for Medical Research, Manhasset, New York, USA
    PLoS ONE 8:e63734. 2013
    ....
  40. doi Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder
    Raphael J Braga
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Department of Psychiatry Research, Glen Oaks, NY, USA
    Psychiatry Res 200:242-5. 2012
    ..Interestingly, bipolar patients with history of CUD had better neurocognitive performance as compared to patients with no history of CUD...
  41. doi Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction
    Katherine E Burdick
    Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 73:103-12. 2012
    ..We evaluated the effects of the dopamine D₂/D₃ receptor agonist pramipexole on cognition in bipolar disorder...
  42. doi Volumetric and shape analysis of the thalamus in first-episode schizophrenia
    Denise M Coscia
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York, USA
    Hum Brain Mapp 30:1236-45. 2009
    ..Our findings suggest that thalamic abnormalities are evident at the onset of a first episode of schizophrenia prior to extensive pharmacologic intervention and that these abnormalities have neuropsychological correlates...
  43. pmc Relationship between suicidality and impulsivity in bipolar I disorder: a diffusion tensor imaging study
    Katie Mahon
    Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA
    Bipolar Disord 14:80-9. 2012
    ..Although white matter abnormalities have been implicated in the pathophysiology of bipolar disorder, their relationship to impulsivity and suicidality in this disorder has not been well-investigated...
  44. ncbi Decision-making impairments in adolescents with early-onset schizophrenia
    Hana M Kester
    Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Schizophr Res 85:113-23. 2006
    ..These findings have potential implications for understanding the increased vulnerability for the development of substance abuse in adolescents with schizophrenia...
  45. ncbi Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates
    Joseph P Rhinewine
    Department of Psychiatry Research Zucker Hillside Hospital, Glen Oaks, New York 11004, USA
    Biol Psychiatry 58:705-12. 2005
    ..Information concerning the severity, pattern, and clinical correlates of these deficits in EOS remains limited...
  46. pmc Resting-state FMRI connectivity impairment in schizophrenia and bipolar disorder
    Miklos Argyelan
    To whom correspondence should be addressed Psychiatry Research, Zucker Hillside Hospital, North Shore LIJ Health System, 75 59 263rd Street, Glen Oaks, NY 11004, US tel 718 470 4486, fax 718 343 1659, E mail
    Schizophr Bull 40:100-10. 2014
    ..Few studies have compared connectivity across the brain in these disorders or investigated their functional correlates...
  47. pmc A voxel-based diffusion tensor imaging study of white matter in bipolar disorder
    Katie Mahon
    Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Neuropsychopharmacology 34:1590-600. 2009
    ..Our findings are consistent with models of bipolar disorder that implicate dysregulation of cortico-subcortical and cerebellar regions in the disorder and may have relevance for phenomenology...
  48. doi Pharmacogenetic approaches to cognitive enhancement in schizophrenia
    Katherine E Burdick
    Albert Einstein College of Medicine, USA
    Harv Rev Psychiatry 19:102-8. 2011
    ..In this review, we discuss the potential use of cognition as a primary outcome measure of interest in future pharmacogenetic trials of schizophrenia...
  49. pmc A role for white matter abnormalities in the pathophysiology of bipolar disorder
    Katie Mahon
    Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY, USA
    Neurosci Biobehav Rev 34:533-54. 2010
    ..Taken together, the evidence supports and clarifies a model of BD that involves disconnectivity in regions implicated in emotion generation and regulation...
  50. pmc Meta-analysis of genetic variation in DTNBP1 and general cognitive ability
    Jian Ping Zhang
    The Zucker Hillside Hospital, Glen Oaks, New York, USA
    Biol Psychiatry 68:1126-33. 2010
    ..We examined the relationship between DTNBP1 SNPs and general cognitive ability in nonpsychiatric healthy samples via meta-analysis...
  51. pmc MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults
    George C Nitzburg
    Division of Psychiatry Research, The Zucker Hillside Hospital, United States Electronic address
    Schizophr Res 152:223-8. 2014
    ..To date, however, there is no performance data for the MCCB in healthy children and adolescents. The present study sought to establish performance data for the MCCB in healthy children, adolescents, and young adults...
  52. pmc Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder
    Dana Anderson
    The Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset
    Bipolar Disord 15:680-93. 2013
    ....
  53. pmc Dopaminergic influences on emotional decision making in euthymic bipolar patients
    Katherine E Burdick
    Department of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Neuropsychopharmacology 39:274-82. 2014
    ..Our results suggest that the enhancement of dopaminergic activity influences risk-associated decision-making performance in euthymic BPD. The clinical implications remain unknown. ..
  54. ncbi Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression
    Joseph F Goldberg
    Department of Psychiatry, Weill Medical College of Cornell University, New York, NY, USA
    Am J Psychiatry 161:564-6. 2004
    ..The authors conducted a preliminary randomized, placebo-controlled trial to determine the safety and antidepressant efficacy of pramipexole in treatment-resistant bipolar depression...
  55. ncbi Levetiracetam for acute mania
    Joseph F Goldberg
    Am J Psychiatry 159:148. 2002
  56. ncbi Association of education and cognitive status in Brazilian elderly institutionalized patients with schizophrenia
    Ursula Vega
    Schizophr Res 78:107-9. 2005

Research Grants1

  1. Neurocognition as an endophenotype in bipolar disorder
    Katherine Burdick; Fiscal Year: 2008
    ....